Akso Health Group (AHG) intrinsic value & 10-year financials
Akso Health Group (AHG) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 5.5% a year to $13.8M, with an average return on invested capital of -95.1%.
- Graham intrinsic value
- —
- Revenue (FY2026)
- $13.8M
- Revenue growth (10-yr CAGR)
- -5.5%
- ROIC (10-yr avg)
- -95.1%
- Free cash flow (FY2026)
- -$12.8M
AHG 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2026 | $13.8M | -$18.7M | $0.01 | -$12.8M | -149.7% | -18.4% |
| FY2025 | $14.8M | -$135.0M | -$0.16 | $1.0M | -1125.4% | -590.5% |
| FY2024 | $2.4M | -$9.5M | -$0.01 | — | -357.8% | -11.7% |
| FY2023 | $13.2M | -$1.4M | -$0.00 | — | -108.2% | -135.8% |
| FY2022 | $6.3M | -$16.9M | -$0.02 | -$8.6M | -252.5% | -131.3% |
| FY2021 | $1.8M | -$34.8M | -$0.06 | — | -1761.0% | -89.1% |
| FY2020 | $11.4M | -$71.2M | -$0.12 | -$56.2M | -599.3% | -93.7% |
| FY2019 | $61.3M | $5.5M | $0.01 | -$2.7M | 8.3% | 4.3% |
| FY2018 | $107.3M | $65.5M | $0.11 | $87.3M | 70.7% | 79.4% |
| FY2017 | $22.9M | $8.6M | $0.02 | $7.9M | 43.3% | 35.8% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Akso Health Group is facing top-line stagnation, with revenue contracting over the decade.
Akso Health Group has historically struggled to out-earn its cost of capital, averaging just -55.7% ROIC.
Akso Health Group has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Akso Health Group is modeled at -5.5% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.02 per share.